Purchase of Fibroscan standalone liver elastography machine
What the buyer wrote
The Trust required to purchase new standalone liver elastography machine. The 'Fibroscan' is now the gold standard method to assess the degree of liver fibrosis in patients without the need for a biopsy and is used in clinical practice guidelines (including NICE) for many disorders such as Hepatitis B, Hepatitis C and Non-alcoholic fatty liver disease (NAFLD). In recent years, the number of patients being seen in the liver clinic with NAFLD has increased dramatically. This is most commonly related to being overweight. Patients with NAFLD are not only at risk of developing liver fibrosis but also are at risk of heart attacks, strokes and diabetes. The new Fibroscan machines are able to mea…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Purchase of Fibroscan standalone liver elastography machine
- How they are buying
- The buyer did not say
- Type
- goods
- Work starts
- 30 Jun 2020
- Work ends
- 30 Jun 2025
- Kind of work
- Health and social care
Who the buyer named
The buyer published a contact address on this notice.